Speaker illustration

Professor Nikolaus Marx

RWTH University Hospital Aachen, Aachen (Germany)

Member of:

European Society of Cardiology

Modern Glycaemic Management to reduce CV risk in Diabetes

Event: ESC Congress 2021 - The Digital Experience

Topic: Cardiovascular Disease in Special Populations

Session type: Satellite Symposium

Thumbnail

SGLT2 inhibitors and cardiovascular outcomes

Event: ESC CONGRESS 2019

Topic: Pharmacotherapy

Session type: Symposium

Thumbnail

Expanding opportunities for SGLT2i in clinical cardiology

Event: ESC CONGRESS 2019

Topic: Risk Factors and Prevention

Session type: Satellite Symposium

Thumbnail

Evidence, guidelines, clinical practice – The evolving role of cardiologists in the SGLT2 inhibitor era

Event: ESC CONGRESS 2019

Topic: Risk Factors and Prevention

Session type: Satellite Symposium - Experts on the Spot

Thumbnail

Targeting SGLT2 in clinical cardiology: discussing the benefits in cardiovascular risk, diabetes & heart failure

Event: ESC Congress 2018

Topic: Risk Factors and Prevention

Session type: Satellite Symposium - Experts on the Spot

Thumbnail

Targeting SGLT2 in clinical cardiology: exploring the benefits in cardiovascular risk, diabetes & heart failure (EBAC Accredited)

Event: ESC Congress 2018

Topic: Risk Factors and Prevention

Session type: Satellite Symposium

Thumbnail

Reducing cardiovascular mortality in patients with type 2 diabetes: closing the gap between evidence and practice

Event: ESC Congress 2018

Topic: Diabetes and the Heart

Session type: Satellite Symposium

Thumbnail

Treatment of type 2 diabetes - Important new aspects for the cardiologist

Event: ESC CONGRESS 2017

Topic: Drug therapy

Session type: Symposium

Thumbnail

Improving cardiovascular outcomes in patients with type 2 diabetes: where does the evidence lead us?

Event: ESC CONGRESS 2017

Topic: Diabetes, dysglycaemia and metabolic syndrome

Session type: Satellite Symposium

Thumbnail

This platform is supported by

logo Novo Nordisk